Breaking News Instant updates and real-time market news.

INVA

Innoviva

$16.28 /

+0.37 (+2.33%)

, ETTX

Entasis Therapeutics

$1.82 /

-0.015 (-0.82%)

08:32
05/23/22
05/23
08:32
05/23/22
08:32

Innoviva to acquire Entasis Therapeutics for $2.20 per share in cash

Innoviva and Entasis Therapeutics Holdings announced the companies have entered into a definitive merger agreement under which Innoviva is to acquire all of the outstanding shares of Entasis not already owned by Innoviva at a price of $2.20 per share in cash. Innoviva currently owns approximately 60% of the outstanding shares of Entasis common stock. The acquisition consideration values Entasis' equity at $113 million on a fully diluted basis. The transaction has been unanimously approved by the Innoviva and Entasis Boards of Directors. Established in 2015 as a spin-out from AstraZeneca, Entasis' unique pathogen-targeted approach has produced a robust clinical and pre-clinical pipeline of potential first- and best-in-class medicines for the treatment of multidrug-resistant Gram-negative bacteria, including lead asset SUL-DUR. In a Phase 3 registrational trial, SUL-DUR achieved all primary and secondary endpoints and a New Drug Application is expected to be submitted to the U.S. Food and Drug Administration in the third quarter of 2022. Innoviva has been a strategic investor in Entasis since 2020 and holds an equity stake of approximately 60% of the outstanding shares of Entasis common stock. Pursuant to the terms and subject to the conditions of the merger agreement, Innoviva has agreed to purchase all of the issued and outstanding equity securities of Entasis not currently owned by Innoviva via a tender offer, followed by a merger, for consideration of $2.20 per share payable in cash. This represents a 50% premium to Entasis' closing price of $1.47 per share on January 31, 2022, the last date before Innoviva's original bid became public. The transaction, which is subject to customary closing conditions, is anticipated to close in the third quarter of 2022.

INVA

Innoviva

$16.28 /

+0.37 (+2.33%)

ETTX

Entasis Therapeutics

$1.82 /

-0.015 (-0.82%)

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
BitNile' subsidiary Ault Alliance did not acquire EYP » 06:32
07/07/22
07/07
06:32
07/07/22
06:32
NILE

BitNile

/

+

BitNile's subsidiary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NILE BitNile
/

+

NILE BitNile
/

+

03/15/22 Spartan Capital
BitNile initiated with a Buy at Spartan Capital
12/15/21 Ascendiant
BitNile initiated with a Buy at Ascendiant
NILE BitNile
/

+

NILE BitNile
/

+

NILE BitNile
/

+

Recommendations
Mirati Therapeutics price target lowered to $127 from $208 at Citi » 06:31
07/07/22
07/07
06:31
07/07/22
06:31
MRTX

Mirati Therapeutics

$69.87 /

-2.08 (-2.89%)

Citi analyst Yigal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRTX Mirati Therapeutics
$69.87 /

-2.08 (-2.89%)

MRTX Mirati Therapeutics
$69.87 /

-2.08 (-2.89%)

06/07/22 Stifel
Mirati Therapeutics price target raised to $111 from $105 at Stifel
06/07/22 JMP Securities
Mirati Therapeutics upgraded to Outperform from Market Perform at JMP Securities
05/27/22 Stifel
Mirati Therapeutics after-hours move lower 'overdone,' says Stifel
05/20/22 Guggenheim
Guggenheim upgrades Mirati to Buy on adagrasib's 'highly competitive profile'
MRTX Mirati Therapeutics
$69.87 /

-2.08 (-2.89%)

  • 11
    Nov
MRTX Mirati Therapeutics
$69.87 /

-2.08 (-2.89%)

Downgrade
FS Bancorp downgraded to Market Perform from Outperform at Raymond James » 06:29
07/07/22
07/07
06:29
07/07/22
06:29
FSBW

FS Bancorp

$28.95 /

-0.09 (-0.31%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSBW FS Bancorp
$28.95 /

-0.09 (-0.31%)

FSBW FS Bancorp
$28.95 /

-0.09 (-0.31%)

Initiation
CTI BioPharma initiated with an Outperform at Cowen » 06:29
07/07/22
07/07
06:29
07/07/22
06:29
CTIC

CTI BioPharma

$6.01 /

-0.235 (-3.76%)

Cowen analyst Boris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTIC CTI BioPharma
$6.01 /

-0.235 (-3.76%)

CTIC CTI BioPharma
$6.01 /

-0.235 (-3.76%)

04/14/22 Stifel
Stifel reiterates Buy on CTI BioPharma following new treatment guidelines
03/01/22 Brookline
CTI BioPharma price target raised to $12 from $7.20 at Brookline
12/01/21 Lake Street
CTI BioPharma delay creates buying opportunity, says Lake Street
10/04/21 Lake Street
CTI BioPharma should be bought on weakness after PRE-VENT miss, says Lake Street
CTIC CTI BioPharma
$6.01 /

-0.235 (-3.76%)

CTIC CTI BioPharma
$6.01 /

-0.235 (-3.76%)

CTIC CTI BioPharma
$6.01 /

-0.235 (-3.76%)

Downgrade
CytomX Therapeutics downgraded to Neutral from Outperform at Wedbush » 06:28
07/07/22
07/07
06:28
07/07/22
06:28
CTMX

CytomX Therapeutics

$1.96 /

+0.015 (+0.77%)

Wedbush analyst Robert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTMX CytomX Therapeutics
$1.96 /

+0.015 (+0.77%)

CTMX CytomX Therapeutics
$1.96 /

+0.015 (+0.77%)

06:14 Today Barclays
CytomX Therapeutics price target lowered to $3.50 from $7 at Barclays
04:44 Today Mizuho
CytomX Therapeutics downgraded to Neutral from Buy at Mizuho
04:42 Today Piper Sandler
CytomX Therapeutics downgraded to Neutral from Overweight at Piper Sandler
06/23/22 BMO Capital
CytomX Therapeutics initiated with an Outperform at BMO Capital
CTMX CytomX Therapeutics
$1.96 /

+0.015 (+0.77%)

CTMX CytomX Therapeutics
$1.96 /

+0.015 (+0.77%)

Recommendations
Iveric bio price target raised to $30 from $25 at Morgan Stanley » 06:28
07/07/22
07/07
06:28
07/07/22
06:28
ISEE

Iveric bio

$10.44 /

+0.3 (+2.96%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ISEE Iveric bio
$10.44 /

+0.3 (+2.96%)

ISEE Iveric bio
$10.44 /

+0.3 (+2.96%)

06/08/22 Guggenheim
Iveric bio initiated with a Buy at Guggenheim
06/08/22 BofA
Iveric bio initiated with a Buy at BofA
05/12/22 B. Riley
B. Riley puts Neutral rating on Iveric bio in 'contrarian call'
05/12/22 B. Riley
Iveric bio initiated with a Neutral at B. Riley
ISEE Iveric bio
$10.44 /

+0.3 (+2.96%)

  • 22
    Oct
  • 13
    Jul
ISEE Iveric bio
$10.44 /

+0.3 (+2.96%)

Recommendations
Warner Music price target lowered to $27 from $31 at Citi » 06:28
07/07/22
07/07
06:28
07/07/22
06:28
WMG

Warner Music

$25.03 /

-0.6 (-2.34%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WMG Warner Music
$25.03 /

-0.6 (-2.34%)

WMG Warner Music
$25.03 /

-0.6 (-2.34%)

07/05/22 Barclays
Warner Music price target lowered to $33 from $37 at Barclays
06/03/22 Guggenheim
Warner Music price target raised to $34 from $30 at Guggenheim
05/17/22 Citi
Warner Music price target lowered to $31 from $41 at Citi
05/11/22 Barclays
Warner Music price target lowered to $37 from $49 at Barclays
WMG Warner Music
$25.03 /

-0.6 (-2.34%)

  • 04
    Jan
  • 09
    Dec
  • 22
    Sep
  • 09
    Sep
WMG Warner Music
$25.03 /

-0.6 (-2.34%)

Recommendations
Warner Bros. Discovery price target lowered to $29 from $40 at Citi » 06:27
07/07/22
07/07
06:27
07/07/22
06:27
WBD

Warner Bros. Discovery

$14.26 /

-0.195 (-1.35%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WBD Warner Bros. Discovery
$14.26 /

-0.195 (-1.35%)

WBD Warner Bros. Discovery
$14.26 /

-0.195 (-1.35%)

06/29/22 Benchmark
Benchmark starts Warner Bros. Discovery at Buy, expects shares to recover
06/29/22 Benchmark
Warner Bros. Discovery initiated with a Buy at Benchmark
06/16/22 JPMorgan
Warner Bros. Discovery reinstated with a Neutral at JPMorgan
06/02/22 Wolfe Research
Warner Bros. Discovery price target lowered to $20 from $30 at Wolfe Research
WBD Warner Bros. Discovery
$14.26 /

-0.195 (-1.35%)

WBD Warner Bros. Discovery
$14.26 /

-0.195 (-1.35%)

WBD Warner Bros. Discovery
$14.26 /

-0.195 (-1.35%)

WBD Warner Bros. Discovery
$14.26 /

-0.195 (-1.35%)

Recommendations
Disney price target lowered to $145 from $165 at Citi » 06:27
07/07/22
07/07
06:27
07/07/22
06:27
DIS

Disney

$96.07 /

-1.15 (-1.18%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DIS Disney
$96.07 /

-1.15 (-1.18%)

DIS Disney
$96.07 /

-1.15 (-1.18%)

07/05/22 Vertical Group
Disney downgraded to Mixed from Positive at Vertical Group
06/30/22 Morgan Stanley
Disney price target lowered to $125 from $170 at Morgan Stanley
06/15/22 Evercore ISI
Disney showing good financial discipline with IPL renewal, says Evercore ISI
06/06/22 Deutsche Bank
Disney price target lowered to $130 from $191 at Deutsche Bank
DIS Disney
$96.07 /

-1.15 (-1.18%)

DIS Disney
$96.07 /

-1.15 (-1.18%)

DIS Disney
$96.07 /

-1.15 (-1.18%)

DIS Disney
$96.07 /

-1.15 (-1.18%)

Recommendations
Vivid Seats price target lowered to $12 from $14 at Citi » 06:27
07/07/22
07/07
06:27
07/07/22
06:27
SEAT

Vivid Seats

$7.55 /

-0.43 (-5.39%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SEAT Vivid Seats
$7.55 /

-0.43 (-5.39%)

SEAT Vivid Seats
$7.55 /

-0.43 (-5.39%)

05/10/22 Raymond James
Vivid Seats price target lowered to $11 from $17 at Raymond James
03/11/22 Benchmark
Vivid Seats price target lowered to $17 from $19 at Benchmark
01/31/22 Credit Suisse
Vivid Seats initiated with an Outperform at Credit Suisse
01/03/22 Citi
Citi upgrades Vivid Seats to Buy on 'unwarranted' selloff
SEAT Vivid Seats
$7.55 /

-0.43 (-5.39%)

Recommendations
Unity Software price target lowered to $68 from $71 at Citi » 06:27
07/07/22
07/07
06:27
07/07/22
06:27
U

Unity Software

/

+

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
U Unity Software
/

+

U Unity Software
/

+

06/30/22 KeyBanc
Unity Software initiated with a Sector Weight at KeyBanc
06/29/22 BTIG
Unity Software price target lowered to $72 from $110 at BTIG
06/21/22 Credit Suisse
Unity Software price target lowered to $105 from $137 at Credit Suisse
06/16/22 Jefferies
Unity Software price target lowered to $36 from $40 at Jefferies
U Unity Software
/

+

U Unity Software
/

+

U Unity Software
/

+

U Unity Software
/

+

Recommendations
Spotify price target lowered to $150 from $165 at Citi » 06:27
07/07/22
07/07
06:27
07/07/22
06:27
SPOT

Spotify

/

+

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPOT Spotify
/

+

SPOT Spotify
/

+

06/29/22 JPMorgan
Spotify price target lowered to $145 from $150 at JPMorgan
06/15/22 Wells Fargo
Wells Fargo upgrades Spotify to Equal Weight, raises price target to $124
06/15/22 Wells Fargo
Spotify upgraded to Equal Weight from Underweight at Wells Fargo
06/09/22 Goldman Sachs
Spotify price target lowered to $133 from $150 at Goldman Sachs
SPOT Spotify
/

+

SPOT Spotify
/

+

SPOT Spotify
/

+

SPOT Spotify
/

+

Downgrade
Veritex downgraded to Outperform from Strong Buy at Raymond James » 06:26
07/07/22
07/07
06:26
07/07/22
06:26
VBTX

Veritex

/

+

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VBTX Veritex
/

+

VBTX Veritex
/

+

06/13/22 DA Davidson
DA Davidson says recent and pending investments by Veritex support tailwinds
01/27/22 Raymond James
Veritex price target raised to $49 from $46 at Raymond James
10/28/21 Piper Sandler
Veritex price target raised to $46 from $42 at Piper Sandler
09/22/21 DA Davidson
Veritex price target raised to $44 from $40 at DA Davidson
  • 04
    Mar
Recommendations
Sportradar price target lowered to $18 from $23 at Citi » 06:26
07/07/22
07/07
06:26
07/07/22
06:26
SRAD

Sportradar

$7.93 /

-0.39 (-4.69%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRAD Sportradar
$7.93 /

-0.39 (-4.69%)

SRAD Sportradar
$7.93 /

-0.39 (-4.69%)

05/19/22 Benchmark
Sportradar price target lowered to $15 from $30 at Benchmark
05/19/22 Craig-Hallum
Sportradar price target lowered to $25 from $30 at Craig-Hallum
05/19/22 JPMorgan
Sportradar price target lowered to $14 from $24 at JPMorgan
05/19/22 Deutsche Bank
Sportradar price target lowered to $13 from $20 at Deutsche Bank
SRAD Sportradar
$7.93 /

-0.39 (-4.69%)

  • 14
    Sep
SRAD Sportradar
$7.93 /

-0.39 (-4.69%)

Recommendations
Skillz price target lowered to $1.55 from $2.10 at Citi » 06:26
07/07/22
07/07
06:26
07/07/22
06:26
SKLZ

Skillz

$1.37 /

-0.02 (-1.44%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SKLZ Skillz
$1.37 /

-0.02 (-1.44%)

SKLZ Skillz
$1.37 /

-0.02 (-1.44%)

05/23/22 Citi
Skillz downgraded to Neutral from Buy at Citi
03/01/22 Citi
Skillz price target lowered to $5 from $9 at Citi
02/24/22 Stifel
Skillz price target lowered to $3.50 from $16 at Stifel
02/24/22 Wedbush
Skillz price target lowered to $7.50 from $25 at Wedbush
SKLZ Skillz
$1.37 /

-0.02 (-1.44%)

SKLZ Skillz
$1.37 /

-0.02 (-1.44%)

SKLZ Skillz
$1.37 /

-0.02 (-1.44%)

Recommendations
Sirius XM price target lowered to $7.50 from $7.60 at Citi » 06:26
07/07/22
07/07
06:26
07/07/22
06:26
SIRI

Sirius XM

$6.19 /

-0.02 (-0.32%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SIRI Sirius XM
$6.19 /

-0.02 (-0.32%)

SIRI Sirius XM
$6.19 /

-0.02 (-0.32%)

04/19/22 Rosenblatt
Sirius XM initiated with a Buy at Rosenblatt
04/19/22 Rosenblatt
Liberty Sirius XM initiated with a Buy at Rosenblatt
04/18/22 Morgan Stanley
Sirius XM downgraded to Underweight at Morgan Stanley amid auto headwinds
04/18/22 Morgan Stanley
Sirius XM downgraded to Underweight from Equal Weight at Morgan Stanley
SIRI Sirius XM
$6.19 /

-0.02 (-0.32%)

SIRI Sirius XM
$6.19 /

-0.02 (-0.32%)

SIRI Sirius XM
$6.19 /

-0.02 (-0.32%)

Downgrade
PNC Financial downgraded to Market Perform from Outperform at Raymond James » 06:26
07/07/22
07/07
06:26
07/07/22
06:26
PNC

PNC Financial

/

+

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PNC PNC Financial
/

+

PNC PNC Financial
/

+

07/01/22 Oppenheimer
Oppenheimer says U.S. financial institutions 'dramatically undervalued'
05/26/22 Wolfe Research
PNC Financial price target lowered to $177 from $223 at Wolfe Research
04/18/22 Argus
PNC Financial price target lowered to $220 from $245 at Argus
04/18/22 Raymond James
PNC Financial price target lowered to $210 from $215 at Raymond James
PNC PNC Financial
/

+

PNC PNC Financial
/

+

PNC PNC Financial
/

+

Recommendations
Roku price target lowered to $165 from $175 at Citi » 06:26
07/07/22
07/07
06:26
07/07/22
06:26
ROKU

Roku

$88.61 /

-3.5 (-3.80%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROKU Roku
$88.61 /

-3.5 (-3.80%)

ROKU Roku
$88.61 /

-3.5 (-3.80%)

06/17/22 Truist
Deal with Walmart an 'incremental positive' for Roku, says Truist
06/09/22 KeyBanc
KeyBanc 'skeptical' of any Netflix, Roku deal
06/08/22 Benchmark
Acquisition of Roku would be 'heroic departure' for Netflix, says Benchmark
06/08/22 Truist
Truist sees 'industrial logic' to potential Netflix, Roku tie-up
ROKU Roku
$88.61 /

-3.5 (-3.80%)

ROKU Roku
$88.61 /

-3.5 (-3.80%)

ROKU Roku
$88.61 /

-3.5 (-3.80%)

ROKU Roku
$88.61 /

-3.5 (-3.80%)

Recommendations
Roblox price target lowered to $46 from $52 at Citi » 06:25
07/07/22
07/07
06:25
07/07/22
06:25
RBLX

Roblox

$37.94 /

-2.05 (-5.13%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RBLX Roblox
$37.94 /

-2.05 (-5.13%)

RBLX Roblox
$37.94 /

-2.05 (-5.13%)

06/17/22 Truist
Roblox downgraded to Hold from Buy at Truist
06/16/22 MKM Partners
Roblox price target lowered to $28 from $30 at MKM Partners
06/16/22 Morgan Stanley
Roblox price target lowered to $25 from $27 at Morgan Stanley
06/15/22 Stifel
Roblox price target lowered to $40 from $45 at Stifel
RBLX Roblox
$37.94 /

-2.05 (-5.13%)

RBLX Roblox
$37.94 /

-2.05 (-5.13%)

RBLX Roblox
$37.94 /

-2.05 (-5.13%)

RBLX Roblox
$37.94 /

-2.05 (-5.13%)

Upgrade
Texas Capital upgraded to Strong Buy from Outperform at Raymond James » 06:25
07/07/22
07/07
06:25
07/07/22
06:25
TCBI

Texas Capital

$53.10 /

-0.25 (-0.47%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCBI Texas Capital
$53.10 /

-0.25 (-0.47%)

TCBI Texas Capital
$53.10 /

-0.25 (-0.47%)

06/15/22 Truist
Texas Capital price target lowered to $65 from $69 at Truist
01/18/22 BofA
Texas Capital reinstated with a Neutral at BofA
09/02/21 Wedbush
Texas Capital downgraded to Neutral at Wedbush
09/02/21 Janney Montgomery Scott
Janney cuts Texas Capital to Neutral on longer than expected turnaround timeline
TCBI Texas Capital
$53.10 /

-0.25 (-0.47%)

TCBI Texas Capital
$53.10 /

-0.25 (-0.47%)

TCBI Texas Capital
$53.10 /

-0.25 (-0.47%)

Recommendations
Qurate Retail price target lowered to $3 from $4 at Citi » 06:25
07/07/22
07/07
06:25
07/07/22
06:25
QRTEA

Qurate Retail

$2.63 /

-0.34 (-11.45%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QRTEA Qurate Retail
$2.63 /

-0.34 (-11.45%)

QRTEA Qurate Retail
$2.63 /

-0.34 (-11.45%)

02/28/22 BofA
Qurate Retail cut to Neutral at BofA amid competitive and execution issues
02/28/22 BofA
Qurate Retail downgraded to Neutral from Buy at BofA
QRTEA Qurate Retail
$2.63 /

-0.34 (-11.45%)

Recommendations
Playtika price target lowered to $15 from $17 at Citi » 06:25
07/07/22
07/07
06:25
07/07/22
06:25
PLTK

Playtika

$13.70 /

-0.06 (-0.44%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLTK Playtika
$13.70 /

-0.06 (-0.44%)

PLTK Playtika
$13.70 /

-0.06 (-0.44%)

06/22/22 Cowen
Playtika valuation attractive with strong fundamentals, says Cowen
05/12/22 Truist
SciPlay upgraded to Buy from Hold at Truist
05/11/22 MKM Partners
Playtika price target lowered to $17 from $25 at MKM Partners
05/11/22 Wedbush
Playtika price target lowered to $22 from $35 at Wedbush
PLTK Playtika
$13.70 /

-0.06 (-0.44%)

PLTK Playtika
$13.70 /

-0.06 (-0.44%)

PLTK Playtika
$13.70 /

-0.06 (-0.44%)

PLTK Playtika
$13.70 /

-0.06 (-0.44%)

Downgrade
Hilltop Holdings downgraded to Underperform from Market Perform at Raymond James » 06:25
07/07/22
07/07
06:25
07/07/22
06:25
HTH

Hilltop Holdings

$27.43 /

-0.35 (-1.26%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HTH Hilltop Holdings
$27.43 /

-0.35 (-1.26%)

HTH Hilltop Holdings
$27.43 /

-0.35 (-1.26%)

07/26/21 Raymond James
Hilltop Holdings downgraded to Market Perform from Outperform at Raymond James
07/26/21 Raymond James
Hilltop Holdings downgraded to Market Perform from Outperform at Raymond James
HTH Hilltop Holdings
$27.43 /

-0.35 (-1.26%)

HTH Hilltop Holdings
$27.43 /

-0.35 (-1.26%)

HTH Hilltop Holdings
$27.43 /

-0.35 (-1.26%)

Recommendations
Paramount price target lowered to $37 from $44 at Citi » 06:25
07/07/22
07/07
06:25
07/07/22
06:25
PARA

Paramount

$25.06 /

-0.135 (-0.54%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PARA Paramount
$25.06 /

-0.135 (-0.54%)

PARA Paramount
$25.06 /

-0.135 (-0.54%)

07/06/22 BofA
Paramount price target lowered to $28 from $32 at BofA
07/05/22 Vertical Group
Paramount downgraded to Mixed from Positive at Vertical Group
07/01/22 Daiwa
Paramount initiated with a Neutral at Daiwa
06/15/22 Evercore ISI
Disney showing good financial discipline with IPL renewal, says Evercore ISI
PARA Paramount
$25.06 /

-0.135 (-0.54%)

PARA Paramount
$25.06 /

-0.135 (-0.54%)

PARA Paramount
$25.06 /

-0.135 (-0.54%)

PARA Paramount
$25.06 /

-0.135 (-0.54%)

Downgrade
Guaranty Bancshares downgraded to Market Perform from Outperform at Raymond James » 06:24
07/07/22
07/07
06:24
07/07/22
06:24
GNTY

Guaranty Bancshares

$36.41 /

+0.02 (+0.05%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNTY Guaranty Bancshares
$36.41 /

+0.02 (+0.05%)

GNTY Guaranty Bancshares
$36.41 /

+0.02 (+0.05%)

07/08/21 Raymond James
Raymond James starts Guaranty at Outperform on Texas 'tailwinds'
07/08/21 Raymond James
Guaranty Bancshares initiated with an Outperform at Raymond James
GNTY Guaranty Bancshares
$36.41 /

+0.02 (+0.05%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.